Fox, Keith A. A. http://orcid.org/0000-0002-0140-2752
Metra, Marco
Morais, João http://orcid.org/0000-0003-3406-2878
Atar, Dan
Article History
Accepted: 24 June 2019
First Online: 29 July 2019
Competing interests
: Editorial support was funded by Bayer and Janssen Scientific Affairs. K.A.A.F. has received speaker honoraria and consulting fees from AstraZeneca, Bayer/Janssen, Sanofi/Regeneron and Verseon. M.M. has received speaker honoraria and consulting fees for his participation in executive committees, advisory boards or speeches from Amgen, Bayer, Fresenius, Novartis and Servier. J.M. has received speaker honoraria and consulting fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Merck Sharp & Dohme, Novartis and Servier. D.A. has received speaker honoraria and consulting fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Merck Sharp & Dohme and Novartis.